Preclinical data also indicates a promising future in neuroprotection and most likely to expand its clinical utility into neurodegenerative pathologies
Shih-Jen Tsai, Semax, an analogue of adrenocorticotropin (410), is a potential agent for the treatment of attention-deficit hyperactivity disorder and Rett syndrome, Medical Hypotheses, Volume 68, Issue 5, 2007, Pages 1144-1146, ISSN 0306-9877, [Read More]
FormBlends connects you with licensed providers who can evaluate your needs and create a personalized protocol
Most respondents were of European ancestry (78.3%), although the study also included substantial representation from Latino (12.9%) and African American (4.2%) ancestries
It is not approved by the FDA or any regulatory authority for human or veterinary use
Rittenberg L, Morrissey D, El-Khawand D et al: Kenalog injection into hunner's lesions as a treatment for interstitial cystitis/bladder pain syndrome